SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Anuh Pharma informs about press release

28 Apr 2026 Evaluate
Anuh Pharma has informed that the Company has published advertisements in the newspapers Financial Express (English) and Mumbai Lakshdeep (Marathi) editions on Tuesday, 28th April, 2026. This advertisement informs shareholders of Anuh Pharma (‘the Company’) that relate to the initiation of a second phase of 100-day campaign by the Company titled ‘Saksham Niveshak by the Investor Education and Protection Fund Authority (‘IEPFA’), Ministry of Corporate Affairs. Copies of the published advertisements are enclosed herewith. This disclosure is being simultaneously uploaded on the Company’s website: www.anuhpharma.com

The above information is a part of company’s filings submitted to BSE.

Anuh Pharma Share Price

81.99 -0.11 (-0.13%)
30-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.20
Dr. Reddys Lab 1322.95
Cipla 1309.90
Zydus Lifesciences 891.65
Lupin 2303.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×